Destination Wealth Management grew its holdings in Clorox Co (NYSE:CLX) by 2.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 36,737 shares of the company’s stock after buying an additional 894 shares during the quarter. Destination Wealth Management’s holdings in Clorox were worth $5,464,000 as of its most recent SEC filing.
Several other institutional investors have also bought and sold shares of the company. FMR LLC boosted its stake in shares of Clorox by 0.8% in the second quarter. FMR LLC now owns 106,828 shares of the company’s stock worth $14,234,000 after acquiring an additional 879 shares during the last quarter. Verition Fund Management LLC acquired a new stake in shares of Clorox in the second quarter worth approximately $251,000. Perigon Wealth Management LLC boosted its stake in shares of Clorox by 274.1% in the second quarter. Perigon Wealth Management LLC now owns 4,564 shares of the company’s stock worth $608,000 after acquiring an additional 3,344 shares during the last quarter. Eqis Capital Management Inc. boosted its stake in shares of Clorox by 13.4% in the third quarter. Eqis Capital Management Inc. now owns 3,580 shares of the company’s stock worth $472,000 after acquiring an additional 423 shares during the last quarter. Finally, Assenagon Asset Management S.A. acquired a new stake in shares of Clorox in the third quarter worth approximately $233,000. Institutional investors and hedge funds own 74.11% of the company’s stock.
Clorox Co (NYSE CLX) opened at $131.70 on Monday. Clorox Co has a 12 month low of $124.09 and a 12 month high of $150.40. The firm has a market capitalization of $17,042.51, a price-to-earnings ratio of 21.73, a price-to-earnings-growth ratio of 2.47 and a beta of 0.31. The company has a debt-to-equity ratio of 2.35, a quick ratio of 0.86 and a current ratio of 1.22.
Clorox (NYSE:CLX) last announced its quarterly earnings results on Friday, February 2nd. The company reported $1.23 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.22 by $0.01. Clorox had a return on equity of 126.70% and a net margin of 13.21%. The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same quarter in the prior year, the company posted $1.14 EPS. The company’s quarterly revenue was up .7% on a year-over-year basis. equities analysts forecast that Clorox Co will post 6.23 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 11th. Stockholders of record on Wednesday, April 25th will be paid a $0.96 dividend. This represents a $3.84 annualized dividend and a dividend yield of 2.92%. The ex-dividend date is Tuesday, April 24th. This is a positive change from Clorox’s previous quarterly dividend of $0.84. Clorox’s dividend payout ratio is 55.45%.
A number of analysts have recently issued reports on the company. Argus lowered Clorox from a “buy” rating to a “hold” rating and lowered their price target for the stock from $150.40 to $127.81 in a research note on Thursday, February 8th. Zacks Investment Research raised Clorox from a “hold” rating to a “buy” rating and set a $147.00 price target on the stock in a research note on Tuesday, February 6th. BMO Capital Markets set a $147.00 price target on Clorox and gave the stock a “buy” rating in a research note on Monday, February 5th. Bank of America lowered their price target on Clorox from $155.00 to $140.00 and set a “neutral” rating on the stock in a research note on Monday, February 5th. Finally, Morgan Stanley lowered their price target on Clorox from $140.00 to $133.00 and set an “equal weight” rating on the stock in a research note on Monday, February 5th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and four have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $132.46.
In other news, SVP Michael R. Costello sold 10,574 shares of the company’s stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total value of $1,438,169.74. Following the transaction, the senior vice president now owns 34,867 shares of the company’s stock, valued at approximately $4,742,260.67. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 1.00% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Clorox Co (CLX) Stake Increased by Destination Wealth Management” was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright & trademark law. The original version of this story can be accessed at https://ledgergazette.com/2018/02/19/clorox-co-clx-stake-increased-by-destination-wealth-management.html.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.